1. Home
  2. CWST vs GRFS Comparison

CWST vs GRFS Comparison

Compare CWST & GRFS Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo Casella Waste Systems Inc.

CWST

Casella Waste Systems Inc.

HOLD

Current Price

$86.18

Market Cap

5.9B

Sector

Utilities

ML Signal

HOLD

Logo Grifols S.A.

GRFS

Grifols S.A.

HOLD

Current Price

$7.18

Market Cap

5.4B

Sector

Health Care

ML Signal

HOLD

Company Overview

Basic Information
Metric
CWST
GRFS
Founded
1975
1940
Country
United States
Spain
Employees
N/A
25247
Industry
Environmental Services
Biotechnology: Pharmaceutical Preparations
Sector
Utilities
Health Care
Exchange
Nasdaq
Nasdaq
Market Cap
5.9B
5.4B
IPO Year
1997
N/A

Fundamental Metrics

Financial Performance
Metric
CWST
GRFS
Price
$86.18
$7.18
Analyst Decision
Strong Buy
Hold
Analyst Count
7
2
Target Price
$115.71
$10.15
AVG Volume (30 Days)
586.9K
569.5K
Earning Date
04-30-2026
07-28-2022
Dividend Yield
N/A
1.80%
EPS Growth
N/A
N/A
EPS
N/A
N/A
Revenue
$1,836,841,000.00
N/A
Revenue This Year
$10.95
$4.49
Revenue Next Year
$6.97
$6.42
P/E Ratio
N/A
$18.67
Revenue Growth
17.95
N/A
52 Week Low
$74.05
$7.26
52 Week High
$117.46
$11.14

Technical Indicators

Market Signals
Indicator
CWST
GRFS
Relative Strength Index (RSI) 50.11 34.34
Support Level $83.55 N/A
Resistance Level $90.35 $7.73
Average True Range (ATR) 2.92 0.17
MACD -0.23 -0.02
Stochastic Oscillator 40.85 4.39

Price Performance

Historical Comparison
CWST
GRFS

About CWST Casella Waste Systems Inc.

Casella Waste Systems Inc is a solid waste removal company, providing resource management services to residential, commercial, municipal, and industrial customers. The company's reportable segments on Geographical basis include Eastern, Western and Mid-Atlantic regions through the Resource solution segment. It generates maximum revenue from the Western region segment. The company's services include Recycling, Collection, Organics, Energy, Landfills, Special Waste as well as Professional Services.

About GRFS Grifols S.A.

Grifols SA is a healthcare company engaged in activities related to plasma-derived products and diagnostic solutions. The group has four reportable segments: Biopharma, Diagnostic, Bio Supplies, and Others. The Biopharma segment focuses on products derived from human plasma for therapeutic use, while the Diagnostic segment includes the marketing of diagnostic testing equipment and reagents. The Bio Supplies segment covers biological products for non-therapeutic use and plasma sales to third parties, and the Others segment includes manufacturing services, research activities, and complementary pharmaceutical products.

Share on Social Networks: